Inogen, based in Goleta, California, develops portable oxygen concentrators for chronic respiratory patients and went public on February 14, 2014. Their products include Inogen One systems, Inogen Connect, and Simeox airway clearance devices.
Michael J Bourque bought 3,000 shares of INGN on 3 March at $8.32 per share, worth a total of $25K. They now own 47,646 INGN shares, or a 7% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.